Analysis

Arcadia Biosciences, Inc. (RKDA) Stock Analysis

Arcadia Biosciences, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to RKDA.

websiteRKDA/analysis/RKDA

Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to RKDA.

Stock profile

Ticker

RKDA

Asset type

Stock

Market cap

$1.6M

Sector

Process Industries

Industry

Chemicals: Agricultural

Currency

USD

Ticker listings

Arcadia Biosciences, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • RKDA primary listing
  • 17D
  • A3D7B0

Latest Arcadia Biosciences, Inc. news

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

WIXOM, Mich., May 20, 2026--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis products.

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

-- Zola® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia’s history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA...

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

-- Zola® revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination -- -- Exercise of preferred

Research sections

Valuation

Review valuation context for Arcadia Biosciences, Inc..

Future growth

Review future growth context for Arcadia Biosciences, Inc..

Past performance

Review past performance context for Arcadia Biosciences, Inc..

Financial health

Review financial health context for Arcadia Biosciences, Inc..

Dividend

Review dividend context for Arcadia Biosciences, Inc..

Management

Review management context for Arcadia Biosciences, Inc..

Ownership

Review ownership context for Arcadia Biosciences, Inc..

Other information

Review other information context for Arcadia Biosciences, Inc..

Community

Review community context for Arcadia Biosciences, Inc..